Le Blanc K et al. |
Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. |
1998 |
Thromb. Res. |
pmid:9772010
|
Kakishita E et al. |
Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood. |
1990 |
Thromb. Res. |
pmid:2082481
|
Powling MJ and Hardisty RM |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. |
1986 |
Thromb. Res. |
pmid:3787566
|
Siffert W et al. |
Inhibition of platelet aggregation by amiloride. |
1986 |
Thromb. Res. |
pmid:3787567
|
Liu X et al. |
Ginkgolide B inhibits platelet release by blocking Syk and p38 MAPK phosphorylation in thrombin-stimulated platelets. |
2014 |
Thromb. Res. |
pmid:25223809
|
Namm DH and High JA |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity. |
1980 |
Thromb. Res. |
pmid:7209881
|
Juhan-Vague I et al. |
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro. |
1985 |
Thromb. Res. |
pmid:3923649
|
Violi F et al. |
Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate. |
1989 |
Thromb. Res. |
pmid:2506658
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Valone FH |
Platelet-activating factor binding and metabolism during human platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3400077
|
Lalau Keraly C et al. |
Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets. |
1984 |
Thromb. Res. |
pmid:6740569
|
Bernat A and Herbert JM |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF. |
1994 |
Thromb. Res. |
pmid:8073411
|
Valone FH and Johnson B |
Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability. |
1985 |
Thromb. Res. |
pmid:4082115
|
Ostermann G et al. |
The role of lipoproteins in the degradation of platelet-activating factor. |
1986 |
Thromb. Res. |
pmid:3798402
|
Battistini B et al. |
Endothelin-1 does not affect human platelet aggregation in whole blood and platelet rich plasma. |
1990 |
Thromb. Res. |
pmid:2278035
|
Ostermann G et al. |
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. |
1988 |
Thromb. Res. |
pmid:3232123
|
Avdonin PV et al. |
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. |
1988 |
Thromb. Res. |
pmid:3232128
|
Avdonin PV et al. |
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. |
1987 |
Thromb. Res. |
pmid:2438805
|
Mabilat-Pragnon C et al. |
Urokinase localization and activity in isolated eosinophils. |
1997 |
Thromb. Res. |
pmid:9526961
|
Csáki C et al. |
Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. |
1992 |
Thromb. Res. |
pmid:1412179
|
Patterson WR et al. |
Aggregation of killer whale platelets. |
1993 |
Thromb. Res. |
pmid:8327987
|
Inoue Y et al. |
Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats. |
1991 |
Tohoku J. Exp. Med. |
pmid:2063402
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|
Isobe J and Mizuno A |
Aspects of PAF (platelet activating factor)-induced aggregation by using rabbit platelets. |
1982 |
Tokushima J. Exp. Med. |
pmid:7170716
|
Ezoulin MJ et al. |
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. |
2006 |
Toxicol In Vitro |
pmid:16472967
|
Baskin SI et al. |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice. |
1996 |
Toxicol. Appl. Pharmacol. |
pmid:8806852
|
Wright DT et al. |
Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture. |
1994 |
Toxicol. Appl. Pharmacol. |
pmid:8048050
|
Nomura DK et al. |
Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. |
2008 |
Toxicol. Appl. Pharmacol. |
pmid:18164358
|
Samet JM and Friedman M |
Effect of ozone on platelet activating factor metabolism in phorbol-differentiated HL60 cells. |
1992 |
Toxicol. Appl. Pharmacol. |
pmid:1440609
|
Hanslik T et al. |
Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity. |
1994 |
Toxicol. Appl. Pharmacol. |
pmid:8079343
|
Ramos G et al. |
Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. |
2004 |
Toxicol. Appl. Pharmacol. |
pmid:15020195
|
Feuerstein G et al. |
Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. |
1987 |
Toxicol. Lett. |
pmid:3660430
|
Bailie MB et al. |
Platelet activating factor receptor blockade alone or in combination with leukotriene synthesis inhibition does not ameliorate alpha-naphthylisothiocyanate-induced hepatotoxicity. |
1996 |
Toxicol. Lett. |
pmid:8614909
|
Mahgoub AA |
Thymoquinone protects against experimental colitis in rats. |
2003 |
Toxicol. Lett. |
pmid:12749817
|
Flaherty MM et al. |
Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice. |
2012 |
Toxicol. Sci. |
pmid:22025730
|
Grandoni KM et al. |
Trichothecene mycotoxins inhibit phosphoinositide hydrolysis in bovine platelets stimulated with platelet activating factor. |
1992 |
Toxicology |
pmid:1311467
|
Pearson JM et al. |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. |
1997 |
Toxicology |
pmid:9231696
|
Gambero A et al. |
Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. |
2004 |
Toxicon |
pmid:15450921
|
Teixeira CF et al. |
Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). |
1994 |
Toxicon |
pmid:8052996
|
Shiroma N et al. |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs. |
1994 |
Toxicon |
pmid:7846692
|
Havt A et al. |
The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. |
2001 |
Toxicon |
pmid:11600146
|
Castro-Faria-Neto HC et al. |
Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum. |
1991 |
Toxicon |
pmid:1796477
|
Yara A et al. |
Cardiovascular effects of Acanthaster planci venom in the rat: possible involvement of PAF in its hypotensive effect. |
1992 |
Toxicon |
pmid:1440631
|
Rees RS et al. |
Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. |
1988 |
Toxicon |
pmid:3245050
|
Freire-Maia L and de Matos IM |
Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. |
1993 |
Toxicon |
pmid:8266352
|
Tai H et al. |
TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. |
2004 |
Toxicon |
pmid:15501291
|
Melo RC et al. |
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. |
2005 |
Traffic |
pmid:16138901
|
Guerrant RL et al. |
Diarrhea, demography and cell signaling: lessons from microbial toxins. |
1997 |
Trans. Am. Clin. Climatol. Assoc. |
pmid:9108674
|
Shukla SD et al. |
Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity. |
1989 Jul-Aug |
Transfusion |
pmid:2546298
|
Hirt SW et al. |
Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation. |
1992 |
Transpl. Int. |
pmid:14621825
|
Torras J et al. |
Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model. |
1993 |
Transpl. Int. |
pmid:8347271
|
Räisänen A et al. |
Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo. |
1993 |
Transpl. Int. |
pmid:8216700
|
Wang KS et al. |
Protective effects of a PAF antagonist against liver injury induced by warm ischemia or cold preservation. |
1992 |
Transplant. Proc. |
pmid:1496669
|
Takada Y et al. |
Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. |
2000 |
Transplant. Proc. |
pmid:10715416
|
Fukuoka T et al. |
Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. |
1993 |
Transplant. Proc. |
pmid:8470175
|
Peyman JA et al. |
HLA-DR genes are silenced in human trophoblasts and stimulation of signal transduction pathways does not circumvent interferon-gamma unresponsiveness. |
1992 |
Transplant. Proc. |
pmid:1533073
|
Taniguchi S et al. |
Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasmapheresis on cardiac xenograft survival. |
1994 |
Transplant. Proc. |
pmid:8171719
|
Coughlan AF et al. |
In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. |
1993 |
Transplant. Proc. |
pmid:7692651
|
Hammer C et al. |
Xenogeneic rejection mechanisms shown by intravital microscopy. |
1998 |
Transplant. Proc. |
pmid:9865335
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Fukunaga K et al. |
Successful liver transplantation from non-heart-beating donors by blockade of endothelin and PAE. |
1998 |
Transplant. Proc. |
pmid:9838664
|
Lloberas N et al. |
The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. |
2002 |
Transplant. Proc. |
pmid:11959179
|
Castellvi J et al. |
Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. |
2002 |
Transplant. Proc. |
pmid:11959181
|
Metcalfe SM et al. |
Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170. |
1991 |
Transplant. Proc. |
pmid:1871852
|
Pirotzky E et al. |
Cyclosporine-induced nephrotoxicity: preventive effect of a PAF-acether antagonist, BN 52063. |
1988 |
Transplant. Proc. |
pmid:3388505
|
Keskinoglu A et al. |
Inflammatory lipid mediators and immunologic recognition in allogeneic renal transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122948
|
Otte KE et al. |
Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor. |
1990 |
Transplant. Proc. |
pmid:2349668
|
Moreno P et al. |
Changes in peripheral blood levels of platelet-activating factor after orthotopic liver transplantation. |
1993 |
Transplant. Proc. |
pmid:8395105
|
Kecskemeti V and Balogh I |
Cardiac electrophysiologic and ultrastructural effects of platelet-activating factor and its antagonist BN 52021. |
1995 |
Transplant. Proc. |
pmid:7482928
|
Yin M et al. |
Platelet-activating factor antagonist TCV-309 protects rat kidneys against ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7482939
|
Spiegel HU et al. |
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7482955
|
Foegh ML |
Eicosanoids and platelet activating factor mechanisms in organ rejection. |
1988 |
Transplant. Proc. |
pmid:3059615
|
Mahmoud FF et al. |
In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. |
2002 |
Transplant. Proc. |
pmid:12431672
|
Borobia FG et al. |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats. |
1993 |
Transplant. Proc. |
pmid:8356661
|
Toledo-Pereyra LH and Suzuki S |
Cellular and biomolecular mechanisms of liver ischemia and reperfusion injury. |
1994 |
Transplant. Proc. |
pmid:8109001
|
Iwamoto H et al. |
Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. |
2000 |
Transplant. Proc. |
pmid:11119873
|
Da Costa M et al. |
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. |
1990 |
Transplant. Proc. |
pmid:2389490
|
Bergmann R et al. |
Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys. |
1990 |
Transplant. Proc. |
pmid:2389511
|
|
Immunomodulation: other approaches. |
1988 |
Transplant. Proc. |
pmid:3347955
|
Renkonen R et al. |
Second messenger pathways in lymphocyte binding and penetration through graft vascular endothelium. |
1991 |
Transplant. Proc. |
pmid:1846709
|
O'Hair DP et al. |
Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection. |
1992 |
Transplant. Proc. |
pmid:1566490
|
Pignol B et al. |
Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. |
1988 |
Transplant. Proc. |
pmid:3259039
|
Miyatake T et al. |
Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. |
2000 |
Transplant. Proc. |
pmid:10936319
|
|
First International Alexis Carrel Conference on Lipid Mediators in Organ Transplantation. April 8-10, 1986, Washington, DC. |
1986 |
Transplant. Proc. |
pmid:3765055
|
Minor T et al. |
Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft. |
1995 |
Transplant. Proc. |
pmid:7879086
|
Ide S et al. |
Donor administration of PAF antagonist (TCV-309) enhances lung preservation. |
1995 |
Transplant. Proc. |
pmid:7879103
|
Takada Y et al. |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7879169
|
Yin M et al. |
Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7879180
|
Pi F et al. |
Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. |
1994 |
Transplantation |
pmid:8291097
|
Lanese DM et al. |
Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. |
1994 |
Transplantation |
pmid:7809931
|
Makowka L et al. |
Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. |
1990 |
Transplantation |
pmid:2402783
|
Biancone L et al. |
Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation. |
2006 |
Transplantation |
pmid:16495796
|
Gu M et al. |
Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. |
2000 |
Transplantation |
pmid:11045637
|
Saumweber DM et al. |
Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS. |
1994 |
Transplantation |
pmid:8108870
|
Biancone L et al. |
Role of platelet-activating factor in functional alterations induced by xenoreactive antibodies in porcine endothelial cells. |
2000 |
Transplantation |
pmid:11063341
|
Yin M et al. |
The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. |
1996 |
Transplantation |
pmid:8633367
|
Conte JV et al. |
Long-term lung preservation with the PAF antagonist BN 52021. |
1991 |
Transplantation |
pmid:2048190
|
Watson CJ et al. |
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival. |
1993 |
Transplantation |
pmid:8212192
|
Suzuki S et al. |
The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. |
2000 |
Transplantation |
pmid:10868624
|